CommercialCoverageMedium impact
Balloon Dilation of the Eustachian Tube
Blue Cross & Blue Shield of Mississippi·MS · ENT (Ear, Nose & Throat)·Medical Policy
We identified it
Jun 20, 2026
Summary
New medical policy establishes specific criteria for when balloon dilation of the eustachian tube is considered medically necessary versus investigational. The policy requires comprehensive diagnostic workup, failed medical management, and multiple specific clinical criteria to be met for coverage approval.
Action Required
Immediately: Billing team must review all balloon dilation of eustachian tube procedures to ensure comprehensive documentation requirements are met before submission. Providers must document: 12+ months of symptoms in adults 22+, comprehensive diagnostic assessment including tympanometry and audiometry, failed 4-6 weeks nasal steroid treatment, ruled out other causes, demonstrated reversibility via Valsalva maneuver, and continuous (not episodic) symptoms. Claims not meeting these specific criteria will be deemed investigational and denied.